Home › Compare › RVLP vs EQR

RVLP vs EQR: Dividend Comparison 2026

RVLP yields 7092.20% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RVLP wins by $1884093739015635.50M in total portfolio value
10 years
RVLP
RVLP
● Live price
7092.20%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1884093739015635.50M
Annual income
$1,833,245,317,704,596,000,000.00
Full RVLP calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — RVLP vs EQR

📍 RVLP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRVLPEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RVLP + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RVLP pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RVLP
Annual income on $10K today (after 15% tax)
$602,836.88/yr
After 10yr DRIP, annual income (after tax)
$1,558,258,520,048,906,500,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, RVLP beats the other by $1,558,258,520,048,906,500,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RVLP + EQR for your $10,000?

RVLP: 50%EQR: 50%
100% EQR50/50100% RVLP
Portfolio after 10yr
$942046869507817.75M
Annual income
$916,622,658,852,298,000,000.00/yr
Blended yield
97.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

RVLP
Analyst Ratings
6
Buy
Consensus: Buy
Altman Z
-11.5
Piotroski
4/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RVLP buys
0
EQR buys
0
No recent congressional trades found for RVLP or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRVLPEQR
Forward yield7092.20% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$1884093739015635.50M ✓$47.8K
Annual income after 10y$1,833,245,317,704,596,000,000.00 ✓$5,475.61
Total dividends collected$1880686879940887.75M ✓$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: RVLP vs EQR ($10,000, DRIP)

YearRVLP PortfolioRVLP Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$719,920$709,219.86$11,380$679.82+$708.5K → RVLP
2$48,488,208$47,717,893.43$13,014$837.25+$48.48M → RVLP
3$3,055,533,336$3,003,650,953.86$14,961$1,036.20+$3055.52M → RVLP
4$180,164,837,337$176,895,416,667.11$17,297$1,289.22+$180164.82M → RVLP
5$9,940,782,885,418$9,748,006,509,468.02$20,121$1,613.15+$9940782.87M → RVLP
6$513,306,198,719,386$502,669,561,031,988.20$23,561$2,030.84+$513306198.70M → RVLP
7$24,807,223,019,401,092$24,257,985,386,771,350.00$27,783$2,573.54+$24807223019.37M → RVLP
8$1,122,195,624,531,859,500$1,095,651,895,901,100,200.00$33,013$3,284.39+$1122195624531.83M → RVLP
9$47,521,889,075,737,830,000$46,321,139,757,488,740,000.00$39,547$4,223.51+$47521889075737.79M → RVLP
10$1,884,093,739,015,635,500,000$1,833,245,317,704,596,000,000.00$47,791$5,475.61+$1884093739015635.50M → RVLP

RVLP vs EQR: Complete Analysis 2026

RVLP — Stock

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

Full RVLP Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this RVLP vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RVLP vs SCHDRVLP vs JEPIRVLP vs ORVLP vs KORVLP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.